Pharmacology and Clinical Pharmacy Research
Vol 9, No 3 (2024)

Rabeprazole and Domperidone Induced Hyperprolactinemia in a Patient with Type 2 Diabetes Mellitus, Hypothyroidism and Peptic Ulcer Disease: A Case Report

M, Kiran (Unknown)
Chakraborty, Ananya (Unknown)



Article Info

Publish Date
04 Jan 2025

Abstract

Drugs are a common cause of hyperprolactinemia. They are common in patients taking antipsychotics, antiemetics, opioids, antidepressants, prokinetics and proton pump inhibitors (PPI). Rabeprazole is a relatively newer PPI. Domperidone is a well-known prokinetic and antiemetic drug.  There are few reports of hyperprolactinemia & galactorrhea with fixed drug combination (FDC) of rabeprazole (20 mg) and domperidone (30 mg). Here, we report a case of 39-year-old diabetic and hypothyroid female patient who was on the above FDC for peptic ulcer disease on and off for the last four years and developed hyperprolactinemia. She showed neither clinical signs of galactorrhea nor amenorrhea. On routine blood investigations, she had increased prolactin level. Radiological evaluation of brain was normal. The drug was stopped and repeat prolactin was normal within one week of withholding. A diagnosis of rabeprazole and domperidone induced hyperprolactinemia was reached based on clinical, laboratory judgement and causality assessment.

Copyrights © 2024






Journal Info

Abbrev

pcpr

Publisher

Subject

Medicine & Pharmacology

Description

Pharmacology and Clinical Pharmacy Research (PCPR) is an international, peer-reviewed journal, publishing original research, review, case reports, and commentaries on all aspects of pharmacology and clinical pharmacy. The journal aims to contribute to the scientific committee by publishing the high ...